Metastases of colorectal cancer to the liver and peritoneum: comparison of surgical paradigms

References

• Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J. Clin. Oncol.23, 4553–4560 (2005).
   PubMed Web of Science ®Google Scholar
• Hughes KS, Rosenstein RB, Songhorabodi S et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis. Colon Rectum31, 1–4 (1988).
   PubMed Web of Science ®Google Scholar
• Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J. Surg.19, 59–71 (1995).
   PubMed Web of Science ®Google Scholar
• Rosen CB, Nagorney DM, Taswell HF et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg.216, 493–504 (1992).
   PubMed Web of Science ®Google Scholar
• Gayowski TJ, Iwatsuki S, Madariaga JR et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery116, 703–710 (1994).
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer77, 1254–1262 (1996).
   PubMed Web of Science ®Google Scholar
• Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch. Surg.132, 505–510 (1997).
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg.230, 309–318 (1999).
   PubMed Web of Science ®Google Scholar
• Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg.235, 759–766 (2002).
   PubMed Web of Science ®Google Scholar
• Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann. Surg.247, 125–135 (2008).
   PubMed Web of Science ®Google Scholar
• Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg.240, 644–658 (2004).
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surg.221, 124–132 (1995).
   PubMed Web of Science ®Google Scholar
• Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am. Surg.66, 561–568 (2000).
   PubMed Web of Science ®Google Scholar
• Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis. Colon Rectum43, 1341–1348 (2000).
   PubMed Web of Science ®Google Scholar
• Elias D, Blot F, El Otmany A et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer92, 71–76 (2001).
   PubMed Web of Science ®Google Scholar
• Shen P, Hawksworth J, Lovato J et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann. Surg. Oncol.11, 178–186 (2004).
   PubMed Web of Science ®Google Scholar
• Glehen O, Kwiatkowski F, Sugarbaker PH et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J. Clin. Oncol.22, 3284–3292 (2004).
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J. Clin. Oncol.21, 3737–3743 (2003).
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Bundy B, Wenzel L et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med.354, 34–43 (2006).
   PubMed Web of Science ®Google Scholar
• Esquivel J, Sticca R, Sugarbaker P et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann. Surg. Oncol.14, 128–133 (2007).
   PubMed Web of Science ®Google Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg.240, 205–213 (2004).
   PubMed Web of Science ®Google Scholar
• Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg. Oncol. Clin. North Am.12, 531–541 (2003).
   PubMedGoogle Scholar
• Scheele J, Altendorf-Hofmann A. Surgical Treatment of liver metastases. In: Surgery of the Liver and Biliary Tract (3rd Edition). Blumgart LH, Fong Y (Eds). WB Saunders, London, UK 1475–1502 (2000).
   Google Scholar
• Dawson LE, Russell AH, Tong D, Wisbeck WM. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J. Surg. Oncol.22, 95–99 (1983).
   PubMed Web of Science ®Google Scholar
• Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer15(63), 364–367 (1989).
   Google Scholar
• Knorr C, Reingruber B, Meyer T, Hohenberger W, Stremmel C. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Int. J. Colorectal Dis.19, 181–187 (2004).
   PubMed Web of Science ®Google Scholar
• Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N. Engl. J. Med.3, 336, 980–987 (1997).
   Google Scholar
• Wang X, Hershman DL, Abrams JA et al. Predictors of survival after hepatic resection among patients with colorectal liver metastases. Br. J. Cancer97(12), 1606–1612 (2007).
   PubMed Web of Science ®Google Scholar
• Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann. Surg. Oncol.13(5), 668–676 (2006).
   PubMed Web of Science ®Google Scholar
• Figueras J, Torras J, Valls C et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis. Colon Rectum50(4), 478–488 (2007).
   PubMed Web of Science ®Google Scholar
• Tomlinson JS, Jarnagin WR, DeMatteo RP et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol.25(29), 4575–4580 (2007).
   PubMed Web of Science ®Google Scholar
• Kianmanesh R, Scaringi S, Sabate JM et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg245(4), 597–603 (2007).
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, Bruin S, Boot H, Slooten GV, Tinteren HV. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann. Surg. Oncol.15(9), 2426–2432 (2008).
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat. Rev.27, 365–374 (2001).
   PubMed Web of Science ®Google Scholar
• McQuellon RP, Danhauer SC, Russell GB et al. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann. Surg. Oncol.14(3), 1105–1113 (2007).
   PubMed Web of Science ®Google Scholar
• Lincourt AE, Sing RF, Kercher KW et al. Association of demographic and treatment variables in long-term colon cancer survival. Surg. Innov.15, 17–25 (2008).
   PubMed Web of Science ®Google Scholar
• Shen P, Thai K, Stewart JH et al. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann. Surg. Oncol. DOI: 10.1245/s10434-008-0127-4. (2008) (Epub ahead of print).
   Google Scholar